Implementation of a practice guideline for optimal symptom relief in Dutch nursing homes will reduce suffering in patients with dementia and pneumonia.
ID
Bron
Verkorte titel
Aandoening
Dementia, pneumonia
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Suffering (Discomfort: Discomfort Scale – Dementia of Alzheimer Type (DS-DAT); Pain: Pain Assessment In Advanced Dementia (PAINAD); comfort: End Of Life in Dementia – Comfort Assessment in Dying (EOLD-CAD), respiratory difficulty: Respiratory Distress Observation Scale (RDOS)
Achtergrond van het onderzoek
Many people in western countries currently die with dementia. In up to two-thirds of these patients, pneumonia is the terminal event. Earlier work has indicated severe suffering, along with under treatment of symptoms of the pneumonia. Comfort care is appropriate when death is near, but prognostication is difficult.
The PneuMonitor study examines whether suffering in patients with dementia and pneumonia can be reduced by the implementation of an evidence and consensus based practice guideline for optimal symptom relief. This practice guideline was developed using a Delphi study, and consists of a checklist that lists symptoms of pneumonia, observational instruments for dyspnea and pain, and the core guideline that provides information about treatments to relieve symptoms of pneumonia. Matched pairs of thirty-two nursing homes that participated in the study (matched by location, number of psycho geriatric beds and baseline DS-DAT scores) were randomly assigned (cluster-randomization) to the control (usual care) or the intervention group. Regular independent observations for discomfort, pain and respiratory difficulty are performed from diagnosis of pneumonia until cure or death (within 14 days) to examine suffering.
Doel van het onderzoek
Implementation of a practice guideline for optimal symptom relief in Dutch nursing homes will reduce suffering in patients with dementia and pneumonia.
Onderzoeksopzet
Outcomes discomfort, pain and respiratory difficulty and conciousness: observations (when possible) twice daily on the day of diagnosis pneumonia (day 0) and day 1. Daily from day 2 until day 10, and one last time on day 13 or 14 or 15. Survival: minimum 3 months, maximum 3.5 years.
Onderzoeksproduct en/of interventie
A practice guideline for optimal symptom relief based on evidence and consensus among national and international experts.
Publiek
EMGO Institute for Health and Care Research<br>
Department of general practice & elderly care medicine<br>
Van der Boechorststraat 7
J.T. Steen, van der
Amsterdam 1081 BT
The Netherlands
+31 (0)20 4449694
j.vandersteen@vumc.nl
Wetenschappelijk
EMGO Institute for Health and Care Research<br>
Department of general practice & elderly care medicine<br>
Van der Boechorststraat 7
J.T. Steen, van der
Amsterdam 1081 BT
The Netherlands
+31 (0)20 4449694
j.vandersteen@vumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Nursing home residents who reside on a psycho geriatric ward and develop a pneumonia according to clinical judgement (pneumonia most likely diagnosis)
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
None
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4731 |
NTR-old | NTR5071 |
Ander register | NWO : 91711339 |